|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 120.40 USD | -2.28% |
|
-0.68% | +30.35% |
| Capitalization | 149B 127B 119B 112B 206B 13,530B 225B 1,387B 538B 6,378B 560B 549B 23,268B | P/E ratio 2025 * |
17.6x | P/E ratio 2026 * | 16.1x |
|---|---|---|---|---|---|
| Enterprise value | 162B 138B 129B 121B 223B 14,680B 244B 1,505B 584B 6,920B 608B 595B 25,246B | EV / Sales 2025 * |
5.55x | EV / Sales 2026 * | 5.15x |
| Free-Float |
99.9% | Yield 2025 * |
2.75% | Yield 2026 * | 2.87% |
Last Transcript: Gilead Sciences, Inc.
| 1 day | -2.28% | ||
| 1 week | -0.68% | ||
| Current month | -4.32% | ||
| 1 month | -2.43% | ||
| 3 months | +5.11% | ||
| 6 months | +7.45% | ||
| Current year | +30.35% |
| 1 week | 118.78 |  | 123.74 |
| 1 month | 118.78 | | 128.7 |
| Current year | 88.57 | | 128.7 |
| 1 year | 88.57 | | 128.7 |
| 3 years | 62.07 | | 128.7 |
| 5 years | 56.56 | | 128.7 |
| 10 years | 56.56 | | 128.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 60 | 28/02/2019 |
Andrew Dickinson
DFI | Director of Finance/CFO | 55 | 31/10/2019 |
Dietmar Berger
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 57 | 18/08/2016 |
| Director/Board Member | 72 | 31/12/2017 | |
| Director/Board Member | 71 | 08/05/2018 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 13.99% | 303 M€ | -21.05% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.28% | -0.68% | +30.33% | +35.98% | 149B | |
| +1.80% | +1.70% | +31.34% | +179.78% | 920B | |
| +0.75% | +4.78% | +44.68% | +18.97% | 510B | |
| -0.29% | -1.22% | +28.95% | +35.08% | 395B | |
| -0.35% | +1.90% | +23.99% | +4.55% | 340B | |
| -1.12% | -1.09% | +27.21% | +18.45% | 278B | |
| -0.45% | -1.48% | +19.80% | +24.22% | 254B | |
| +1.30% | +0.58% | -0.94% | -7.96% | 249B | |
| +0.45% | +3.73% | -59.06% | -29.63% | 224B | |
| +0.11% | -3.68% | +15.94% | +14.80% | 171B | |
| Average | -0.26% | +0.45% | +16.22% | +29.43% | 349.14B | |
| Weighted average by Cap. | -0.13% | +1.07% | +22.22% | +57.59% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 29.21B 24.88B 23.24B 21.87B 40.26B 2,646B 43.99B 271B 105B 1,247B 110B 107B 4,550B | 30.11B 25.65B 23.96B 22.54B 41.51B 2,727B 45.34B 280B 108B 1,286B 113B 111B 4,690B |
| Net income | 8.28B 7.06B 6.59B 6.2B 11.42B 750B 12.47B 76.94B 29.84B 354B 31.08B 30.42B 1,290B | 8.95B 7.62B 7.12B 6.7B 12.33B 810B 13.47B 83.09B 32.23B 382B 33.57B 32.86B 1,394B |
| Net Debt | 12.7B 10.82B 10.11B 9.51B 17.51B 1,150B 19.13B 118B 45.76B 542B 47.66B 46.65B 1,978B | 5.66B 4.82B 4.5B 4.23B 7.8B 512B 8.52B 52.53B 20.38B 241B 21.22B 20.77B 881B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/12/25 | 120.40 $ | -2.28% | 6,767,829 |
| 11/12/25 | 123.21 $ | +1.54% | 4,892,293 |
| 10/12/25 | 121.34 $ | +1.66% | 8,530,529 |
| 09/12/25 | 119.36 $ | -1.51% | 7,256,046 |
| 08/12/25 | 121.19 $ | -0.02% | 8,870,661 |
Delayed Quote Nasdaq, December 12, 2025 at 09:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GILD Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition